🇵🇭 Country Profile

Philippines

Fast-growing pharmaceutical trade with Philippines

🇵🇭 $449M
All data from DGCIS India export records (fiscal year, April–March).
$449M
Scale
Philippines' patients receive $449M in Indian pharmaceutical products annually, almost entirely finished medicines ready for dispensing.
82%
Medicine
Overwhelmingly finished medicines, drug formulations account for 82% of shipments.
3.5×
Trajectory
One of the faster-growing relationships, India's pharmaceutical supply to Philippines has expanded 3.5× over the decade.
Context
Part of India's pharmaceutical supply network across Asia-Pacific.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Philippines, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicines $368M (82.1%) Vaccines $50.8M (11.3%) Medicine Ingredients $16.1M (3.6%) Surgical & Hospital Supplies $10.0M (2.2%) Traditional & Herbal $3.4M (0.8%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in Philippines Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Philippines: $19.7M across 76 filings (2011-2026).